5 Cheap Small-Cap Stocks to Buy Before the Next Breakout

2. uniQure N.V. (NASDAQ:QURE)

Number of Hedge Fund Investors In Q2 2023: 25

Latest Share Price: $8.93

uniQure N.V. (NASDAQ:QURE) develops treatments for serious diseases such as epilepsy and sclerosis. Its shares are also rated Strong Buy on average and analysts have sent an average share price target of $36.71. However, analysts currently expect the firm to bring in $77 million in revenue for 2023, for a sizeable annual drop

By the end of this year’s June quarter, 25 out of the 910 hedge funds part of Insider Monkey’s research had bought and invested in the firm’s shares. uniQure N.V. (NASDAQ:QURE)’s biggest hedge fund investor is Wilmot B. Harkey and Daniel Mack’s Nantahala Capital Management through its $32.6 million investment.

Follow Uniqure N.v. (NASDAQ:QURE)